AI assistance for dermatologists reading skin lesions
Part of Skin clinical trials.
This study tests whether an AI tool can help dermatologists more accurately identify skin lesions in images. It is for experienced dermatologists who regularly use dermoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a board-certified dermatologist.
- You have clinical experience diagnosing skin lesions with dermoscopy.
- You have completed your specialization in dermatology.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can help general practitioners diagnose skin conditions as accurately as a dermatologist. If you are an adult whose doctor already used OMNIDOC to send a skin image for expert review, you may be able to take part.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
This study tests an AI-enhanced imaging technique to help doctors see the edges of a common type of skin cancer called basal cell carcinoma before surgery. It may help ensure the cancer is removed completely the first time.
Hear when a new Skin Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.